Biocon has informed that the Board of Directors of Biocon (the Company) at its meeting held today, on December 06, 2025 has, transacted the following business: Increase in Authorised Share Capital and consequential amendment to the Memorandum of Association of the Company: Approved the increase in the authorised share capital of the Company from existing Rs. 7,00,00,00,000 (Rupees Seven Hundred Crores Only) divided into 1,40,00,00,000 (One Hundred and Forty Crores) equity shares of Rs. 5 (Rupees Five Only) each to Rs 9,00,00,00,000 (Rupees Nine Hundred Crores Only) divided into 1,80,00,00,000 (One Hundred and Eighty Crores) equity shares of Rs 5 each and consequential amendment to the capital clause of the Memorandum of Association, subject to the receipt of necessary approvals including approval of the Shareholders of the Company and other regulatory / statutory approvals, as may be required, in this regard.

The above information is a part of company’s filings submitted to BSE.